Do companies that work on forward-thinking R&D projects make better products that offer them a competitive advantage? This working paper by Harvard Business School professor Daniel Snow proposes that R&D innovators are much better at incorporating elements from their R&D into current product development.
He focuses on automobile actuators and EPA emissions standards. Are there any lessons here for pharmaceutical process development?
